The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Renal Considerations in Angiotensin Converting Enzyme Inhibitor Therapy: A Statement for Healthcare Professionals From the Council on the Kidney in Cardiovascular Disease and the Council for High Blood Pressure Research of the American Heart Association
Open accessAbstract
The American Heart Association makes every effort to avoid any actual or potential conflicts of interest that may arise as a result of an outside relationship or a personal, professional, or business interest of a member of the writing panel.Specifically, all members of
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
Pitt, B., Zannad, F., Remme, W. J., Cody, R., Castaigne, A., Perez, A., Palensky, J., & Wittes, J. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909023411001 · Cited by 9,214
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663
The SOLVD Investigators* (1991) · New England Journal of Medicine · doi:10.1056/nejm199108013250501 · Cited by 8,029
Pfeffer, M. A., Braunwald, E., Moyé, L. A., Basta, L., Brown, E. J., Cuddy, T. E., Davis, B. R., Geltman, E. M., Goldman, S., Flaker, G. C., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199209033271001 · Cited by 5,911
The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy
Lewis, E. J., Hunsicker, L. G., Bain, R. P., & Rohde, R. D. (1993) · New England Journal of Medicine · doi:10.1056/nejm199311113292004 · Cited by 5,394
Effects of Enalapril on Mortality in Severe Congestive Heart Failure
The Consensus Trial Study Group* (1987) · New England Journal of Medicine · doi:10.1056/nejm198706043162301 · Cited by 5,121
Swedberg, K., & Kjekshus, J. (1988) · The American Journal of Cardiology · doi:10.1016/s0002-9149(88)80087-0 · Cited by 3,762
Garg, R. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03520420066040 · Cited by 1,771
Maschio, G., Alberti, D., Janin, G., Locatelli, F., Mann, J. F. E., Motolese, M., Ponticelli, C., Ritz, E., & Zucchelli, P. (1996) · New England Journal of Medicine · doi:10.1056/nejm199604113341502 · Cited by 1,766
Pitt, B., Segal, R., Martinez, F. A., Meurers, G., Cowley, A. J., Thomas, I., Deedwania, P. C., Ney, D. E., Snavely, D. B., & Chang, P. I. (1997) · The Lancet · doi:10.1016/s0140-6736(97)01187-2 · Cited by 1,665
Angiotensin-Converting Enzyme Inhibitors
Brown, N. J., & Vaughan, D. E. (1998) · Circulation · doi:10.1161/01.cir.97.14.1411 · Cited by 958
Ruggenenti, P., Perna, A., Gherardi, G., Garini, G., Zoccali, C., Salvadori, M., Scolari, F., Schena, F. P., & Remuzzi, G. (1999) · The Lancet · doi:10.1016/s0140-6736(98)10363-x · Cited by 910
Dries, D. L., Exner, D. V., Domanski, M. J., Greenberg, B., & Stevenson, L. W. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00608-7 · Cited by 879
Bakris, G. L., & Weir, M. R. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.5.685 · Cited by 823
Whelton, A. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00113-8 · Cited by 704
Renoprotective benefits of RAS inhibition: From ACEI to angiotensin II antagonists
Taal, M. W., & Brenner, B. M. (2000) · Kidney International · doi:10.1046/j.1523-1755.2000.00031.x · Cited by 439
Argenziano, M., Chen, J. M., Choudhri, A. F., Cullinane, S., Garfein, E., Weinberg, A. D., Smith, C. R., Rose, E. A., Landry, D. W., & Oz, M. C. (1998) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(98)70049-2 · Cited by 393
Effects of Celecoxib and Naproxen on Renal Function in the Elderly
Whelton, A., Schulman, G., Wallemark, C., Drower, E. J., Isakson, P. C., Verburg, K. M., & Geis, G. S. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.10.1465 · Cited by 280
Aggravated renal dysfunction during intensive therapy for advanced chronic heart failure
Weinfeld, M. S., Chertow, G. M., & Stevenson, L. W. (1999) · American Heart Journal · doi:10.1016/s0002-8703(99)70113-4 · Cited by 278
Angiotensin II in central nervous system physiology
Phillips, M. I., & Sumners, C. (1998) · Regulatory Peptides · doi:10.1016/s0167-0115(98)00122-0 · Cited by 245
Reardon, L. C., & Macpherson, D. S. (1998) · Archives of Internal Medicine · doi:10.1001/archinte.158.1.26 · Cited by 222
PACKER, M., LEE, W. H., MEDINA, N., YUSHAK, M., & KESSLER, P. D. (1987) · Annals of Internal Medicine · doi:10.7326/0003-4819-106-3-346 · Cited by 216
Apperloo, A. J., de Zeeuw, D., & de Jong, P. E. (1997) · Kidney International · doi:10.1038/ki.1997.111 · Cited by 205
Risk of morbidity from renovascular disease in elderly patients with congestive cardiac failure
MacDowall, P., Kalra, P., O'Donoghue, D., Waldek, S., Mamtora, H., & Brown, K. (1998) · The Lancet · doi:10.1016/s0140-6736(97)11060-1 · Cited by 178
Textor, S. C., Bravo, E. L., Fouad, F. M., & Tarazi, R. C. (1982) · The American Journal of Medicine · doi:10.1016/0002-9343(82)90415-6 · Cited by 168
Chin, M. H. (1996) · Archives of Internal Medicine · doi:10.1001/archinte.156.16.1814 · Cited by 166
Knight, E. L., Glynn, R. J., McIntyre, K. M., Mogun, H., & Avorn, J. (1999) · American Heart Journal · doi:10.1016/s0002-8703(99)70009-8 · Cited by 166
Toto, R. D., Mitchell, H. C., Lee, H.-C., Milam, C., & Pettinger, W. A. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-7-513 · Cited by 133
Packer, M., Medina, N., Yushak, M., & Meller, J. (1983) · Circulation · doi:10.1161/01.cir.68.4.803 · Cited by 131
Levine, T. B., OLIVARI, M. T., Garberg, V. R., Sharkey, S. W., & Cohn, J. N. (1984) · Circulation · doi:10.1161/01.cir.69.3.548 · Cited by 122
Packer, M., Medina, N., & Yushak, M. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-100-6-782 · Cited by 121
The Angiotensin-converting Enzyme Inhibition Post Revascularization Study (APRES)
Kjøller‐Hansen, L., Steffensen, R., & Grande, P. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00634-8 · Cited by 110
Navis, G., Faber, H. J., de Zeeuw, D., & de Jong, P. E. (1996) · Drug Safety · doi:10.2165/00002018-199615030-00005 · Cited by 93
Angiotensin-converting enzyme inhibitor-induced renal failure
Hricik, D. E., & Dunn, M. J. (1990) · Journal of the American Society of Nephrology · doi:10.1681/asn.v16845 · Cited by 93
Renal failure related to angiotensin-converting enzyme inhibitors.
Textor, S. C. (1997) · PubMed · Cited by 76
Long-term follow-up of acute renal failure caused by angiotensin converting enzyme inhibitors
Wynckel, A., Ebikili, B., Melin, J., Randoux, C., Lavaud, S., & Chanard, J. (1998) · American Journal of Hypertension · doi:10.1016/s0895-7061(98)00117-4 · Cited by 67
Oster, J. R. (1992) · Archives of Internal Medicine · doi:10.1001/archinte.1992.00400160022006 · Cited by 58
Devoy, M. A. B., Tomson, C., Edmunds, M. E., Feehally, J., & Walls, J. (1992) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1992.tb00622.x · Cited by 53
Davidson, N. C., Coutie, W. J., Webb, D. J., & Struthers, A. D. (1996) · Heart · doi:10.1136/hrt.75.6.576 · Cited by 47
Suki, W. N. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.1989.00390030125024 · Cited by 46
Stys, T. P., Lawson, W. E., Smaldone, G. C., & Stys, A. T. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.10.1409 · Cited by 45
The interaction of ACE inhibitors and aspirin in heart failure: Torn between two lovers
Teerlink, J. R., & Massie, B. M. (1999) · American Heart Journal · doi:10.1016/s0002-8703(99)70099-2 · Cited by 37
Risk-Benefit Ratio of Angiotensin Antagonists versus ACE Inhibitors in End-Stage Renal Disease
Sica, D. A., Gehr, T. W. B., & Fernandez, A. (2000) · Drug Safety · doi:10.2165/00002018-200022050-00003 · Cited by 30
Self-citationKubo, S., Nishioka, A., Nishimura, H., Kawamura, K., & Takatsu, T. (1984) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1984.204 · Cited by 22
Acute Tubular Necrosis due to Captopril
Shohaib, S. A., & Raweily, E. A. (2000) · American Journal of Nephrology · doi:10.1159/000013573 · Cited by 20
Webb, C. M. (1998) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/s1010-7940(97)00284-4 · Cited by 17
Aggravated renal dysfunction and the acute management of advanced chronic heart failure
Bart, B. A., & Goldsmith, S. R. (1999) · American Heart Journal · doi:10.1016/s0002-8703(99)70101-8 · Cited by 13
Cited by
Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
Wanner, C., Inzucchi, S. E., Lachin, J. M., Fitchett, D., von Eynatten, M., Mattheus, M., Johansen, O. E., Woerle, H. J., Broedl, U. C., & Zinman, B. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1515920 · Cited by 3,655
Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome
Tarr, P. I., Gordon, C. A., & Chandler, W. L. (2005) · The Lancet · doi:10.1016/s0140-6736(05)71144-2 · Cited by 1,774
Heywood, J. T., Fonarow, G. C., Costanzo, M. R., Mathur, V. S., Wigneswaran, J. R., & Wynne, J. (2007) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2007.03.011 · Cited by 786
Garrick, R. (2008) · Yearbook of Medicine · doi:10.1016/s0084-3873(08)79141-7 · Cited by 556
Kulik, A., Ruel, M., Jneid, H., Ferguson, T. B., Hiratzka, L. F., Ikonomidis, J. S., Lopez-Jimenez, F., McNallan, S. M., Patel, M., Roger, V. L., et al. (2015) · Circulation · doi:10.1161/cir.0000000000000182 · Cited by 448
Self-citation
Metadata
- Authors
- Schoolwerth, A. C., Sica, D. A., Ballermann, B. J., & Wilcox, C. S.
- Venue
- Circulation
- Published
- 2001-10-16
- Volume
- 104
- Issue
- 16
- Pages
- 1985-1991
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W1974994009
- Cited by
- 363
- References
- 48
- FWCI
- 7.94
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.